Memory disorders in 8,037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine-raubasine.
Centre de Gérontologie, Unité INSERM, Paris, France.
J
J
Poitrenaud
B
B
Laurent
C
C
Sebban
D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000523:psychology*; D015765:Almitrine / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D005194:Family Practice; D005500:Follow-Up Studies; D006801:Humans; D008569:Memory Disorders / Q000188:drug therapy*; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D046948:Secologanin Tryptamine Alkaloids; D015016:Yohimbine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D004338:Drug Combinations; D018696:Neuroprotective Agents; D046948:Secologanin Tryptamine Alkaloids; D015016:Yohimbine; C005709:raubasine; D015765:Almitrine